DiaMedica Therapeutics Inc

DMAC · Minneapolis, MN

Works in Cardiovascular · Hematology · Immunology · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Women's health

DiaMedica Therapeutics Inc is a clinical trial sponsor based in Minneapolis, MN, listed as DMAC. It has 1 active clinical trial with 728 planned participants, across 8 therapeutic areas. Since 2021 it has completed 3 trials and stopped 1 early.

Trial track record · since 2021

1Active trials728 planned participants
3Completed0 with results posted
1Stopped earlyterminated, withdrawn or suspended

Financials · DMAC

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 1 active trial

StageTrialStatus

Questions about DiaMedica Therapeutics Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-14.

Approve Suite is not affiliated with DiaMedica Therapeutics Inc.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.